(Q42539201)

1 November 2017

title

Response of segmental vitiligo to 0.05% clobetasol propionate cream (English)

1 reference

1 November 2017

1 reference

Khalid M

1

1 reference

1 November 2017

Mujtaba G

series ordinal

2

1 reference

1 November 2017

publication date

1 September 1998

1 reference

International Journal of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

37

1 reference

1 November 2017

issue

9

1 reference

1 November 2017

page(s)

705-708

1 reference

Vitiligo: a new classification and therapy

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1998.00557.X

A double-blind trial of 0.05% clobetasol proprionate in the treatment of vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1998.00557.X

Clinical features and course of type A and type B vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1998.00557.X

Psoralen therapy in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1998.00557.X

Vitiligo. A symptom complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1998.00557.X

Segmental vitiligo: clinical findings in 208 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1998.00557.X

Non-psoralen treatment of vitiligo. Part I. Cosmetics, systemic coloring agents, and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1998.00557.X

10.1046/J.1365-4362.1998.00557.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference